Related Experiment Videos

Progesterone receptor antagonists and selective progesterone receptor modulators (SPRMs)

Irving M Spitz¹

¹Institute of Hormone Research, Shaare Zedek Medical Center, Jerusalem, Israel. irving@spitz.com

Seminars in Reproductive Medicine

|February 17, 2005

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Mifepristone: Reflections on its Early Clinical Development for Medical Abortion.

Rambam Maimonides medical journal·2026

Three Giants in the Cradle of Reproductive Medicine; Reproduction Theories of the Seventeenth Century as Discerned by Pregnancy Portraiture in the Oeuvre of Jan Vermeer.

Rambam Maimonides medical journal·2016

Mifepristone: where do we come from and where are we going? Clinical development over a quarter of a century.

Contraception·2010

Free alpha-subunit is the most sensitive marker of gonadotropin recovery after treatment of central precocious puberty with the histrelin implant.

The Journal of clinical endocrinology and metabolism·2010

Relationships between FSH, inhibin B, anti-Mullerian hormone, and testosterone during long-term treatment with the GnRH-agonist histrelin in patients with prostate cancer.

European journal of endocrinology·2009

Clinical utility of progesterone receptor modulators and their effect on the endometrium.

Current opinion in obstetrics & gynecology·2009

See all related articles